Product Details

Imoxat 250 mg + 62.5 mg spot-on solution for large dogs

• MA holder: Chanelle Pharmaceuticals Manufacturing Ltd
• VM number: EU/2/21/280/005
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 29/03/2022
• Authorisation route: Centralised
• Active substances:
  • Imidacloprid
  • Moxidectin
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: POM-V